GlassScriptPhysician profile
Stephanie E Varghese
NPI 1538509567
$9,724.20
in general payments reported to CMS, 2019-2025
39 companies · $2,304 in 2025
The $2,304 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $721 · 2020: $1,586 · 2021: $3,197 · 2022: $256 · 2023: $759 · 2024: $902 · 2025: $2,304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,884 · Travel and Lodging: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,883.60 |
| Travel and Lodging | $1,080.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,074.24 | 2021-2025 | |
| Liberty Surgical INC. | $1,232.50 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $911.68 | 2020-2021 | |
| Paladin Technology Solutions | $862.93 | 2024-2025 | |
| Musculoskeletal Transplant Foundation INC. | $718.51 | 2020 | |
| Organogenesis INC. | $604.11 | 2021-2025 | Via Matrix, Novachor, Cygnus Dual |
| Smith+Nephew, INC. | $556.50 | 2019-2025 | Collagenase Santyl |
| Stryker Corporation | $492.42 | 2019-2025 | Easyfuse, Ortholoc 3di |
| Paratek Pharmaceuticals, INC. | $390.11 | 2021-2025 | Nuzyra |
| Averitas Pharma INC. | $361.00 | 2023-2025 | Qutenza |
| Convatec INC. | $283.79 | 2023-2025 | |
| Amgen INC. | $248.11 | 2024-2025 | Krystexxa |
| Melinta Therapeutics, LLC | $131.20 | 2019 | |
| Nevro Corp. | $108.74 | 2022-2023 | Senza |
| Horizon Therapeutics Plc | $79.29 | 2023 | Krystexxa |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $61.26 | 2024-2025 | Xperience, Blastx, Surgx |
| International Rehabilitative Sciences, INC | $57.35 | 2023 | Rs 4i Plus Sequential Stimulator |
| Vertex Pharmaceuticals Incorporated | $51.21 | 2024-2025 | |
| Sebela Pharmaceuticals INC. | $43.16 | 2019-2020 | |
| Bioventus LLC | $40.64 | 2021-2024 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $36.67 | 2024-2025 | Physio-Stim |
| Nabriva Therapeutics, Plc | $29.63 | 2020-2021 | |
| Hartmann USA, INC. | $28.56 | 2023 | Zetuvit Plus |
| Misonix INC | $26.90 | 2020-2021 | |
| Kerecis Limited | $26.57 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Tei Medical INC. | $26.50 | 2019 | |
| Merck Sharp & Dohme LLC | $25.09 | 2019 | |
| Integra Lifesciences Corporation | $23.48 | 2019 | |
| Acumed LLC | $23.21 | 2019 | |
| Kci USA, INC. | $20.93 | 2023 | Activ.A.C., Promogran Prisma, Silvercel |
| Pacira Pharmaceuticals Incorporated | $19.08 | 2025 | Exparel |
| Solventum Corporation | $18.83 | 2025 | Activ.A.C. |
| Anika Therapeutics, INC. | $18.21 | 2022 | |
| Urgo Medical North America, LLC | $17.50 | 2024 | Urgok2 |
| Zimmer Biomet Holdings, INC. | $16.73 | 2019 | |
| Treace Medical Concepts, INC. | $16.68 | 2025 | |
| Paragon 28, INC. | $14.11 | 2023 | Tenotac 2.0 |
| Glenmark Therapeutics INC. | $14.00 | 2019 | |
| Arthrosurface Incorporated | $12.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Varghese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.